Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1996 Jul;9(3):361–381. doi: 10.1128/cmr.9.3.361

Varicella-zoster virus.

A M Arvin 1
PMCID: PMC172899  PMID: 8809466

Abstract

Varicella-zoster virus (VZV) is a ubiquitous human alphaherpesvirus that causes varicella (chicken pox) and herpes zoster (shingles). Varicella is a common childhood illness, characterized by fever, viremia, and scattered vesicular lesions of the skin. As is characteristic of the alphaherpesviruses, VZV establishes latency in cells of the dorsal root ganglia. Herpes zoster, caused by VZV reactivation, is a localized, painful, vesicular rash involving one or adjacent dermatomes. The incidence of herpes zoster increases with age or immunosuppression. The VZV virion consists of a nucleocapsid surrounding a core that contains the linear, double-stranded DNA genome; a protein tegument separates the capsid from the lipid envelope, which incorporates the major viral glycoproteins. VZV is found in a worldwide geographic distribution but is more prevalent in temperate climates. Primary VZV infection elicits immunoglobulin G (IgG), IgM, and IgA antibodies, which bind to many classes of viral proteins. Virus-specific cellular immunity is critical for controlling viral replication in healthy and immunocompromised patients with primary or recurrent VZV infections. Rapid laboratory confirmation of the diagnosis of varicella or herpes zoster, which can be accomplished by detecting viral proteins or DNA, is important to determine the need for antiviral therapy. Acyclovir is licensed for treatment of varicella and herpes zoster, and acyclovir, valacyclovir, and famciclovir are approved for herpes zoster. Passive antibody prophylaxis with varicella-zoster immune globulin is indicated for susceptible high-risk patients exposed to varicella. A live attenuated varicella vaccine (Oka/Merck strain) is now recommended for routine childhood immunization.

Full Text

The Full Text of this article is available as a PDF (438.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessi E., Cusini M., Zerboni R., Cavicchini S., Uberti-Foppa C., Galli M., Moroni M. Unusual varicella zoster virus infection in patients with the acquired immunodeficiency syndrome. Arch Dermatol. 1988 Jul;124(7):1011–1013. [PubMed] [Google Scholar]
  2. Amlie-Lefond C., Kleinschmidt-DeMasters B. K., Mahalingam R., Davis L. E., Gilden D. H. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol. 1995 Jun;37(6):784–790. doi: 10.1002/ana.410370612. [DOI] [PubMed] [Google Scholar]
  3. Anderson D. R., Schwartz J., Hunter N. J., Cottrill C., Bisaccia E., Klainer A. S. Varicella hepatitis: a fatal case in a previously healthy, immunocompetent adult. Report of a case, autopsy, and review of the literature. Arch Intern Med. 1994 Sep 26;154(18):2101–2106. [PubMed] [Google Scholar]
  4. Arbeter A. M., Starr S. E., Plotkin S. A. Varicella vaccine studies in healthy children and adults. Pediatrics. 1986 Oct;78(4 Pt 2):748–756. [PubMed] [Google Scholar]
  5. Arvin A. M. Cell-mediated immunity to varicella-zoster virus. J Infect Dis. 1992 Aug;166 (Suppl 1):S35–S41. doi: 10.1093/infdis/166.supplement_1.s35. [DOI] [PubMed] [Google Scholar]
  6. Arvin A. M., Kinney-Thomas E., Shriver K., Grose C., Koropchak C. M., Scranton E., Wittek A. E., Diaz P. S. Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol. 1986 Aug 15;137(4):1346–1351. [PubMed] [Google Scholar]
  7. Arvin A. M., Koropchak C. M., Williams B. R., Grumet F. C., Foung S. K. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis. 1986 Sep;154(3):422–429. doi: 10.1093/infdis/154.3.422. [DOI] [PubMed] [Google Scholar]
  8. Arvin A. M., Koropchak C. M., Wittek A. E. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis. 1983 Aug;148(2):200–205. doi: 10.1093/infdis/148.2.200. [DOI] [PubMed] [Google Scholar]
  9. Arvin A. M., Kushner J. H., Feldman S., Baehner R. L., Hammond D., Merigan T. C. Human leukocyte interferon for the treatment of varicella in children with cancer. N Engl J Med. 1982 Apr 1;306(13):761–765. doi: 10.1056/NEJM198204013061301. [DOI] [PubMed] [Google Scholar]
  10. Arvin A. M., Sharp M., Smith S., Koropchak C. M., Diaz P. S., Kinchington P., Ruyechan W., Hay J. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J Immunol. 1991 Jan 1;146(1):257–264. [PubMed] [Google Scholar]
  11. Asano Y., Itakura N., Hiroishi Y., Hirose S., Nagai T., Ozaki T., Yazaki T., Yamanishi K., Takahashi M. Viremia is present in incubation period in nonimmunocompromised children with varicella. J Pediatr. 1985 Jan;106(1):69–71. doi: 10.1016/s0022-3476(85)80468-6. [DOI] [PubMed] [Google Scholar]
  12. Asano Y., Itakura N., Hiroishi Y., Hirose S., Ozaki T., Kuno K., Nagai T., Yazaki T., Yamanishi K., Takahashi M. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. J Infect Dis. 1985 Nov;152(5):863–868. doi: 10.1093/infdis/152.5.863. [DOI] [PubMed] [Google Scholar]
  13. Asano Y., Itakura N., Kajita Y., Suga S., Yoshikawa T., Yazaki T., Ozaki T., Yamanishi K., Takahashi M. Severity of viremia and clinical findings in children with varicella. J Infect Dis. 1990 Jun;161(6):1095–1098. doi: 10.1093/infdis/161.6.1095. [DOI] [PubMed] [Google Scholar]
  14. Asano Y., Nakayama H., Yazaki T., Kato R., Hirose S. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics. 1977 Jan;59(1):3–7. [PubMed] [Google Scholar]
  15. Asano Y., Suga S., Yoshikawa T., Kobayashi I., Yazaki T., Shibata M., Tsuzuki K., Ito S. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics. 1994 Oct;94(4 Pt 1):524–526. [PubMed] [Google Scholar]
  16. Balducci J., Rodis J. F., Rosengren S., Vintzileos A. M., Spivey G., Vosseller C. Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol. 1992 Jan;79(1):5–6. [PubMed] [Google Scholar]
  17. Balfour H. H., Jr, Benson C., Braun J., Cassens B., Erice A., Friedman-Kien A., Klein T., Polsky B., Safrin S. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr. 1994 Mar;7(3):254–260. [PubMed] [Google Scholar]
  18. Balfour H. H., Jr, Rotbart H. A., Feldman S., Dunkle L. M., Feder H. M., Jr, Prober C. G., Hayden G. F., Steinberg S., Whitley R. J., Goldberg L. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr. 1992 Apr;120(4 Pt 1):627–633. doi: 10.1016/s0022-3476(05)82495-3. [DOI] [PubMed] [Google Scholar]
  19. Balfour H. H., Jr Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. Am J Med. 1988 Aug 29;85(2A):68–73. [PubMed] [Google Scholar]
  20. Barnes D. W., Whitley R. J. CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy. Neurol Clin. 1986 Feb;4(1):265–283. [PubMed] [Google Scholar]
  21. Bennett G. J. Hypotheses on the pathogenesis of herpes zoster-associated pain. Ann Neurol. 1994;35 (Suppl):S38–S41. doi: 10.1002/ana.410350712. [DOI] [PubMed] [Google Scholar]
  22. Bergen R. E., Sharp M., Sanchez A., Judd A. K., Arvin A. M. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral Immunol. 1991 Fall;4(3):151–166. doi: 10.1089/vim.1991.4.151. [DOI] [PubMed] [Google Scholar]
  23. Berger R., Florent G., Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun. 1981 Apr;32(1):24–27. doi: 10.1128/iai.32.1.24-27.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Beutner K. R., Friedman D. J., Forszpaniak C., Andersen P. L., Wood M. J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995 Jul;39(7):1546–1553. doi: 10.1128/aac.39.7.1546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Biron K. K., Elion G. B. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob Agents Chemother. 1980 Sep;18(3):443–447. doi: 10.1128/aac.18.3.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Bogger-Goren S., Baba K., Hurley P., Yabuuchi H., Takahashi M., Ogra P. L. Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis. 1982 Aug;146(2):260–265. doi: 10.1093/infdis/146.2.260. [DOI] [PubMed] [Google Scholar]
  27. Bogger-Goren S., Bernstein J. M., Gershon A. A., Ogra P. L. Mucosal cell-mediated immunity to varicella zoster virus: role in protection against disease. J Pediatr. 1984 Aug;105(2):195–199. doi: 10.1016/s0022-3476(84)80112-2. [DOI] [PubMed] [Google Scholar]
  28. Boivin G., Edelman C. K., Pedneault L., Talarico C. L., Biron K. K., Balfour H. H., Jr Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS. J Infect Dis. 1994 Jul;170(1):68–75. doi: 10.1093/infdis/170.1.68. [DOI] [PubMed] [Google Scholar]
  29. Brinker J. P., Doern G. V. Comparison of MRC-5 and A-549 cells in conventional culture tubes and shell vial assays for the detection of varicella-zoster virus. Diagn Microbiol Infect Dis. 1993 Jul;17(1):75–77. doi: 10.1016/0732-8893(93)90075-i. [DOI] [PubMed] [Google Scholar]
  30. Brunell P. A., Gershon A. A., Uduman S. A., Steinberg S. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis. 1975 Jul;132(1):49–54. doi: 10.1093/infdis/132.1.49. [DOI] [PubMed] [Google Scholar]
  31. Brunell P. A. Transmission of chickenpox in a school setting prior to the observed exanthem. Am J Dis Child. 1989 Dec;143(12):1451–1452. doi: 10.1001/archpedi.1989.02150240073020. [DOI] [PubMed] [Google Scholar]
  32. Brunell P. A. Varicella in pregnancy, the fetus, and the newborn: problems in management. J Infect Dis. 1992 Aug;166 (Suppl 1):S42–S47. doi: 10.1093/infdis/166.supplement_1.s42. [DOI] [PubMed] [Google Scholar]
  33. Buchbinder S. P., Katz M. H., Hessol N. A., Liu J. Y., O'Malley P. M., Underwood R., Holmberg S. D. Herpes zoster and human immunodeficiency virus infection. J Infect Dis. 1992 Nov;166(5):1153–1156. doi: 10.1093/infdis/166.5.1153. [DOI] [PubMed] [Google Scholar]
  34. Cohen J. I., Seidel K. E. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7376–7380. doi: 10.1073/pnas.90.15.7376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cohen J. I., Seidel K. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J Virol. 1994 Dec;68(12):7850–7858. doi: 10.1128/jvi.68.12.7850-7858.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Cohen P. R., Grossman M. E. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection--a review of the literature. Clin Exp Dermatol. 1989 Jul;14(4):273–276. doi: 10.1111/j.1365-2230.1989.tb01978.x. [DOI] [PubMed] [Google Scholar]
  37. Cohrs R. J., Barbour M. B., Mahalingam R., Wellish M., Gilden D. H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol. 1995 Apr;69(4):2674–2678. doi: 10.1128/jvi.69.4.2674-2678.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Cohrs R. J., Srock K., Barbour M. B., Owens G., Mahalingam R., Devlin M. E., Wellish M., Gilden D. H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol. 1994 Dec;68(12):7900–7908. doi: 10.1128/jvi.68.12.7900-7908.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Cohrs R., Mahalingam R., Dueland A. N., Wolf W., Wellish M., Gilden D. H. Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis. 1992 Aug;166 (Suppl 1):S24–S29. doi: 10.1093/infdis/166.supplement_1.s24. [DOI] [PubMed] [Google Scholar]
  40. Colebunders R., Mann J. M., Francis H., Bila K., Izaley L., Ilwaya M., Kakonde N., Quinn T. C., Curran J. W., Piot P. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis. 1988 Feb;157(2):314–318. doi: 10.1093/infdis/157.2.314. [DOI] [PubMed] [Google Scholar]
  41. Connelly B. L., Stanberry L. R., Bernstein D. I. Detection of varicella-zoster virus DNA in nasopharyngeal secretions of immune household contacts of varicella. J Infect Dis. 1993 Nov;168(5):1253–1255. doi: 10.1093/infdis/168.5.1253. [DOI] [PubMed] [Google Scholar]
  42. Cowan M. R., Primm P. A., Scott S. M., Abramo T. J., Wiebe R. A. Serious group A beta-hemolytic streptococcal infections complicating varicella. Ann Emerg Med. 1994 Apr;23(4):818–822. doi: 10.1016/s0196-0644(94)70320-5. [DOI] [PubMed] [Google Scholar]
  43. Croen K. D., Ostrove J. M., Dragovic L. J., Straus S. E. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9773–9777. doi: 10.1073/pnas.85.24.9773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Cuthbertson G., Grose C. Biotinylated and radioactive DNA probes for detection of varicella-zoster virus genome in infected human cells. Mol Cell Probes. 1988 Sep;2(3):197–207. doi: 10.1016/0890-8508(88)90004-7. [DOI] [PubMed] [Google Scholar]
  45. Davison A. J., Edson C. M., Ellis R. W., Forghani B., Gilden D., Grose C., Keller P. M., Vafai A., Wroblewska Z., Yamanishi K. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol. 1986 Mar;57(3):1195–1197. doi: 10.1128/jvi.57.3.1195-1197.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Davison A. J., Scott J. E. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 1986 Sep;67(Pt 9):1759–1816. doi: 10.1099/0022-1317-67-9-1759. [DOI] [PubMed] [Google Scholar]
  47. Debrus S., Sadzot-Delvaux C., Nikkels A. F., Piette J., Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol. 1995 May;69(5):3240–3245. doi: 10.1128/jvi.69.5.3240-3245.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Devlin M. E., Gilden D. H., Mahalingam R., Dueland A. N., Cohrs R. Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis. 1992 Apr;165(4):619–622. doi: 10.1093/infdis/165.4.619. [DOI] [PubMed] [Google Scholar]
  49. Diaz P. S., Au D., Smith S., Amylon M., Link M., Smith S., Arvin A. M. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics. 1991 Feb;87(2):166–170. [PubMed] [Google Scholar]
  50. Dolin R., Reichman R. C., Mazur M. H., Whitley R. J. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep;89(3):375–388. doi: 10.7326/0003-4819-89-3-375. [DOI] [PubMed] [Google Scholar]
  51. Drew W. L., Mintz L. Rapid diagnosis of varicella-zoster virus infection by direct immunofluorescence. Am J Clin Pathol. 1980 May;73(5):699–701. doi: 10.1093/ajcp/73.5.699. [DOI] [PubMed] [Google Scholar]
  52. Dueland A. N., Devlin M., Martin J. R., Mahalingam R., Cohrs R., Manz H., Trombley I., Gilden D. Fatal varicella-zoster virus meningoradiculitis without skin involvement. Ann Neurol. 1991 May;29(5):569–572. doi: 10.1002/ana.410290520. [DOI] [PubMed] [Google Scholar]
  53. Dunkle L. M., Arvin A. M., Whitley R. J., Rotbart H. A., Feder H. M., Jr, Feldman S., Gershon A. A., Levy M. L., Hayden G. F., McGuirt P. V. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991 Nov 28;325(22):1539–1544. doi: 10.1056/NEJM199111283252203. [DOI] [PubMed] [Google Scholar]
  54. Dworsky M., Whitley R., Alford C. Herpes zoster in early infancy. Am J Dis Child. 1980 Jun;134(6):618–619. doi: 10.1001/archpedi.1980.02130180074021. [DOI] [PubMed] [Google Scholar]
  55. Earnshaw D. L., Bacon T. H., Darlison S. J., Edmonds K., Perkins R. M., Vere Hodge R. A. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother. 1992 Dec;36(12):2747–2757. doi: 10.1128/aac.36.12.2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Enders G., Miller E., Cradock-Watson J., Bolley I., Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994 Jun 18;343(8912):1548–1551. doi: 10.1016/s0140-6736(94)92943-2. [DOI] [PubMed] [Google Scholar]
  57. Englund J. A., Arvin A. M., Balfour H. H., Jr Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children. J Clin Microbiol. 1990 Oct;28(10):2327–2330. doi: 10.1128/jcm.28.10.2327-2330.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Englund J. A., Suarez C. S., Kelly J., Tate D. Y., Balfour H. H., Jr Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. J Pediatr. 1989 Jan;114(1):37–44. doi: 10.1016/s0022-3476(89)80598-0. [DOI] [PubMed] [Google Scholar]
  59. Esiri M. M., Tomlinson A. H. Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci. 1972;15(1):35–48. doi: 10.1016/0022-510x(72)90120-7. [DOI] [PubMed] [Google Scholar]
  60. Esmann V., Geil J. P., Kroon S., Fogh H., Peterslund N. A., Petersen C. S., Ronne-Rasmussen J. O., Danielsen L. Prednisolone does not prevent post-herpetic neuralgia. Lancet. 1987 Jul 18;2(8551):126–129. doi: 10.1016/s0140-6736(87)92331-2. [DOI] [PubMed] [Google Scholar]
  61. Feldhoff C. M., Balfour H. H., Jr, Simmons R. L., Najarian J. S., Mauer S. M. Varicella in children with renal transplants. J Pediatr. 1981 Jan;98(1):25–31. doi: 10.1016/s0022-3476(81)80527-6. [DOI] [PubMed] [Google Scholar]
  62. Feldman S. R., Ford M. J., Briggaman R. A. Herpes zoster and facial palsy. Cutis. 1988 Dec;42(6):523–524. [PubMed] [Google Scholar]
  63. Feldman S., Hughes W. T., Kim H. Y. Herpes zoster in children with cancer. Am J Dis Child. 1973 Aug;126(2):178–184. doi: 10.1001/archpedi.1973.02110190156009. [DOI] [PubMed] [Google Scholar]
  64. Feldman S., Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics. 1987 Oct;80(4):465–472. [PubMed] [Google Scholar]
  65. Feusner J. H., Slichter S. J., Harker L. A. Mechanisms of thrombocytopenia in varicella. Am J Hematol. 1979;7(3):255–264. doi: 10.1002/ajh.2830070308. [DOI] [PubMed] [Google Scholar]
  66. Fleisher G., Henry W., McSorley M., Arbeter A., Plotkin S. Life-threatening complications of varicella. Am J Dis Child. 1981 Oct;135(10):896–899. doi: 10.1001/archpedi.1981.02130340008004. [DOI] [PubMed] [Google Scholar]
  67. Forghani B., Ni L., Grose C. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology. 1994 Mar;199(2):458–462. doi: 10.1006/viro.1994.1145. [DOI] [PubMed] [Google Scholar]
  68. Forghani B., Yu G. J., Hurst J. W. Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization. J Clin Microbiol. 1991 Mar;29(3):583–591. doi: 10.1128/jcm.29.3.583-591.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Friedman S. M., Margo C. E., Connelly B. L. Varicella-zoster virus retinitis as the initial manifestation of the acquired immunodeficiency syndrome. Am J Ophthalmol. 1994 Apr 15;117(4):536–538. doi: 10.1016/s0002-9394(14)70020-0. [DOI] [PubMed] [Google Scholar]
  70. Furuta Y., Takasu T., Fukuda S., Sato-Matsumura K. C., Inuyama Y., Hondo R., Nagashima K. Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J Infect Dis. 1992 Nov;166(5):1157–1159. doi: 10.1093/infdis/166.5.1157. [DOI] [PubMed] [Google Scholar]
  71. Gershon A. A. Human immune responses to live attenuated varicella vaccine. Rev Infect Dis. 1991 Nov-Dec;13 (Suppl 11):S957–S959. doi: 10.1093/clind/13.supplement_11.s957. [DOI] [PubMed] [Google Scholar]
  72. Gershon A. A., LaRussa P., Hardy I., Steinberg S., Silverstein S. Varicella vaccine: the American experience. J Infect Dis. 1992 Aug;166 (Suppl 1):S63–S68. doi: 10.1093/infdis/166.supplement_1.s63. [DOI] [PubMed] [Google Scholar]
  73. Gershon A. A., Sherman D. L., Zhu Z., Gabel C. A., Ambron R. T., Gershon M. D. Intracellular transport of newly synthesized varicella-zoster virus: final envelopment in the trans-Golgi network. J Virol. 1994 Oct;68(10):6372–6390. doi: 10.1128/jvi.68.10.6372-6390.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Gershon A. A., Steinberg S. P. Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections. Infect Immun. 1979 Jul;25(1):170–174. doi: 10.1128/iai.25.1.170-174.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Gershon A. A., Steinberg S. P., Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis. 1984 Feb;149(2):137–142. doi: 10.1093/infdis/149.2.137. [DOI] [PubMed] [Google Scholar]
  76. Gershon A. A., Steinberg S. P., Gelb L., Galasso G., Borkowsky W., LaRussa P., Farrara A. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA. 1984 Jul 20;252(3):355–362. doi: 10.1001/jama.252.3.355. [DOI] [PubMed] [Google Scholar]
  77. Gershon A. A., Steinberg S. P., LaRussa P., Ferrara A., Hammerschlag M., Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis. 1988 Jul;158(1):132–137. doi: 10.1093/infdis/158.1.132. [DOI] [PubMed] [Google Scholar]
  78. Gershon A. A., Steinberg S. P. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Infect Dis. 1990 Apr;161(4):661–666. doi: 10.1093/infdis/161.4.661. [DOI] [PubMed] [Google Scholar]
  79. Gershon A. A., Steinberg S. P. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med. 1989 Apr 6;320(14):892–897. doi: 10.1056/NEJM198904063201403. [DOI] [PubMed] [Google Scholar]
  80. Gershon A. A., Steinberg S., Brunell P. A. Zoster immune globulin. A further assessment. N Engl J Med. 1974 Jan 31;290(5):243–245. doi: 10.1056/NEJM197401312900503. [DOI] [PubMed] [Google Scholar]
  81. Gershon A. A., Steinberg S., Silber R. Varicella-zoster viremia. J Pediatr. 1978 Jun;92(6):1033–1034. doi: 10.1016/s0022-3476(78)80410-7. [DOI] [PubMed] [Google Scholar]
  82. Gershon A. A. Varicella-zoster virus: prospects for control. Adv Pediatr Infect Dis. 1995;10:93–124. [PubMed] [Google Scholar]
  83. Gershon A., Steinberg S., Greenberg S., Taber L. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J Clin Microbiol. 1980 Dec;12(6):764–767. doi: 10.1128/jcm.12.6.764-767.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Ghatak N. R., Zimmerman H. M. Spinal ganglion in herpes zoster. A light and electron microscopic study. Arch Pathol. 1973 Jun;95(6):411–415. [PubMed] [Google Scholar]
  85. Gilchrest B., Baden H. P. Photodistribution of viral exanthems. Pediatrics. 1974 Aug;54(2):136–138. [PubMed] [Google Scholar]
  86. Gilden D. H., Beinlich B. R., Rubinstien E. M., Stommel E., Swenson R., Rubinstein D., Mahalingam R. Varicella-zoster virus myelitis: an expanding spectrum. Neurology. 1994 Oct;44(10):1818–1823. doi: 10.1212/wnl.44.10.1818. [DOI] [PubMed] [Google Scholar]
  87. Gilden D. H., Dueland A. N., Devlin M. E., Mahalingam R., Cohrs R. Varicella-zoster virus reactivation without rash. J Infect Dis. 1992 Aug;166 (Suppl 1):S30–S34. doi: 10.1093/infdis/166.supplement_1.s30. [DOI] [PubMed] [Google Scholar]
  88. Gilden D. H., Mahalingam R., Dueland A. N., Cohrs R. Herpes zoster: pathogenesis and latency. Prog Med Virol. 1992;39:19–75. [PubMed] [Google Scholar]
  89. Gilden D. H., Wright R. R., Schneck S. A., Gwaltney J. M., Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol. 1994 May;35(5):530–533. doi: 10.1002/ana.410350505. [DOI] [PubMed] [Google Scholar]
  90. Giller R. H., Winistorfer S., Grose C. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis. 1989 Dec;160(6):919–928. doi: 10.1093/infdis/160.6.919. [DOI] [PubMed] [Google Scholar]
  91. Gleaves C. A., Lee C. F., Bustamante C. I., Meyers J. D. Use of murine monoclonal antibodies for laboratory diagnosis of varicella-zoster virus infection. J Clin Microbiol. 1988 Sep;26(9):1623–1625. doi: 10.1128/jcm.26.9.1623-1625.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Gnann J. W., Jr New antivirals with activity against varicella-zoster virus. Ann Neurol. 1994;35 (Suppl):S69–S72. doi: 10.1002/ana.410350720. [DOI] [PubMed] [Google Scholar]
  93. Gogos C. A., Bassaris H. P., Vagenakis A. G. Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment. Respiration. 1992;59(6):339–343. doi: 10.1159/000196084. [DOI] [PubMed] [Google Scholar]
  94. Gold E. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection. N Engl J Med. 1966 Jan 27;274(4):181–185. doi: 10.1056/NEJM196601272740403. [DOI] [PubMed] [Google Scholar]
  95. Goodpasture E. W., Anderson K. Infection of Human Skin, Grafted on the Chorioallantois of Chick Embryos, with the Virus of Herpes Zoster. Am J Pathol. 1944 May;20(3):447–455. [PMC free article] [PubMed] [Google Scholar]
  96. Gray F., Bélec L., Lescs M. C., Chrétien F., Ciardi A., Hassine D., Flament-Saillour M., de Truchis P., Clair B., Scaravilli F. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain. 1994 Oct;117(Pt 5):987–999. doi: 10.1093/brain/117.5.987. [DOI] [PubMed] [Google Scholar]
  97. Gray W. L., Pumphrey C. Y., Ruyechan W. T., Fletcher T. M. The simian varicella virus and varicella zoster virus genomes are similar in size and structure. Virology. 1992 Feb;186(2):562–572. doi: 10.1016/0042-6822(92)90022-h. [DOI] [PubMed] [Google Scholar]
  98. Grose C. Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs. Rev Infect Dis. 1991 Nov-Dec;13 (Suppl 11):S960–S963. doi: 10.1093/clind/13.supplement_11.s960. [DOI] [PubMed] [Google Scholar]
  99. Grose C., Ng T. I. Intracellular synthesis of varicella-zoster virus. J Infect Dis. 1992 Aug;166 (Suppl 1):S7–12. doi: 10.1093/infdis/166.supplement_1.s7. [DOI] [PubMed] [Google Scholar]
  100. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics. 1981 Nov;68(5):735–737. [PubMed] [Google Scholar]
  101. Grossman M. C., Grossman M. E. Chronic hyperkeratotic herpes zoster and human immunodeficiency virus infection. J Am Acad Dermatol. 1993 Feb;28(2 Pt 2):306–308. doi: 10.1016/0190-9622(93)70041-q. [DOI] [PubMed] [Google Scholar]
  102. Guess H. A., Broughton D. D., Melton L. J., 3rd, Kurland L. T. Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics. 1985 Oct;76(4):512–517. [PubMed] [Google Scholar]
  103. Guess H. A., Broughton D. D., Melton L. J., 3rd, Kurland L. T. Population-based studies of varicella complications. Pediatrics. 1986 Oct;78(4 Pt 2):723–727. [PubMed] [Google Scholar]
  104. Gustafson T. L., Lavely G. B., Brawner E. R., Jr, Hutcheson R. H., Jr, Wright P. F., Schaffner W. An outbreak of airborne nosocomial varicella. Pediatrics. 1982 Oct;70(4):550–556. [PubMed] [Google Scholar]
  105. HOPE-SIMPSON R. E. THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med. 1965 Jan;58:9–20. [PMC free article] [PubMed] [Google Scholar]
  106. Haake D. A., Zakowski P. C., Haake D. L., Bryson Y. J. Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis. 1990 Sep-Oct;12(5):788–798. doi: 10.1093/clinids/12.5.788. [DOI] [PubMed] [Google Scholar]
  107. Halloran M. E., Cochi S. L., Lieu T. A., Wharton M., Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol. 1994 Jul 15;140(2):81–104. doi: 10.1093/oxfordjournals.aje.a117238. [DOI] [PubMed] [Google Scholar]
  108. Hammerschlag M. R., Gershon A. A., Steinberg S. P., Clarke L., Gelb L. D. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis. 1989 Sep;160(3):535–537. doi: 10.1093/infdis/160.3.535. [DOI] [PubMed] [Google Scholar]
  109. Han C. S., Miller W., Haake R., Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant. 1994 Mar;13(3):277–283. [PubMed] [Google Scholar]
  110. Hardy I., Gershon A. A., Steinberg S. P., LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991 Nov 28;325(22):1545–1550. doi: 10.1056/NEJM199111283252204. [DOI] [PubMed] [Google Scholar]
  111. Hayward A. R., Herberger M. Lymphocyte responses to varicella zoster virus in the elderly. J Clin Immunol. 1987 Mar;7(2):174–178. doi: 10.1007/BF00916011. [DOI] [PubMed] [Google Scholar]
  112. Hayward A. R., Pontesilli O., Herberger M., Laszlo M., Levin M. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells. J Virol. 1986 Apr;58(1):179–184. doi: 10.1128/jvi.58.1.179-184.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Hayward A. R. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J Virol. 1990 Feb;64(2):651–655. doi: 10.1128/jvi.64.2.651-655.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Hayward A., Levin M., Wolf W., Angelova G., Gilden D. Varicella-zoster virus-specific immunity after herpes zoster. J Infect Dis. 1991 Apr;163(4):873–875. doi: 10.1093/infdis/163.4.873. [DOI] [PubMed] [Google Scholar]
  115. Heineman T. C., Cohen J. I. Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. J Virol. 1994 May;68(5):3317–3323. doi: 10.1128/jvi.68.5.3317-3323.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Hellinger W. C., Bolling J. P., Smith T. F., Campbell R. J. Varicella-zoster virus retinitis in a patient with AIDS-related complex: case report and brief review of the acute retinal necrosis syndrome. Clin Infect Dis. 1993 Feb;16(2):208–212. doi: 10.1093/clind/16.2.208. [DOI] [PubMed] [Google Scholar]
  117. Hickling J. K., Borysiewicz L. K., Sissons J. G. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol. 1987 Nov;61(11):3463–3469. doi: 10.1128/jvi.61.11.3463-3469.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Hilt D. C., Buchholz D., Krumholz A., Weiss H., Wolinsky J. S. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol. 1983 Nov;14(5):543–553. doi: 10.1002/ana.410140509. [DOI] [PubMed] [Google Scholar]
  119. Hogan E. L., Krigman M. R. Herpes zoster myelitis. Evidence for viral invasion of spinal cord. Arch Neurol. 1973 Nov;29(5):309–313. doi: 10.1001/archneur.1973.00490290049004. [DOI] [PubMed] [Google Scholar]
  120. Huang Y. C., Lin T. Y., Chiu C. H. Acyclovir prophylaxis of varicella after household exposure. Pediatr Infect Dis J. 1995 Feb;14(2):152–154. [PubMed] [Google Scholar]
  121. Huff J. C., Bean B., Balfour H. H., Jr, Laskin O. L., Connor J. D., Corey L., Bryson Y. J., McGuirt P. Therapy of herpes zoster with oral acyclovir. Am J Med. 1988 Aug 29;85(2A):84–89. [PubMed] [Google Scholar]
  122. Huff J. C., Drucker J. L., Clemmer A., Laskin O. L., Connor J. D., Bryson Y. J., Balfour H. H., Jr Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol. 1993;Suppl 1:93–96. doi: 10.1002/jmv.1890410518. [DOI] [PubMed] [Google Scholar]
  123. Hughes P., LaRussa P., Pearce J. M., Lepow M., Steinberg S., Gershon A. Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction. J Pediatr. 1994 Jun;124(6):932–935. doi: 10.1016/s0022-3476(05)83185-3. [DOI] [PubMed] [Google Scholar]
  124. Hurley J. K., Greenslade T., Lewy P. R., Ahmadian Y., Firlit C. Varicella-zoster infections in pediatric renal transplant recipients. Arch Surg. 1980 Jun;115(6):751–752. doi: 10.1001/archsurg.1980.01380060049012. [DOI] [PubMed] [Google Scholar]
  125. Hurwitz E. S., Goodman R. A. A cluster of cases of Reye syndrome associated with chickenpox. Pediatrics. 1982 Dec;70(6):901–906. [PubMed] [Google Scholar]
  126. Ihara T., Kamiya H., Torigoe S., Sakurai M., Takahashi M. Viremic phase in a leukemic child after live varicella vaccination. Pediatrics. 1992 Jan;89(1):147–149. [PubMed] [Google Scholar]
  127. Ilobi C. P., Martin B. A. A simple and sensitive assay for varicella-zoster virus. J Virol Methods. 1989 Feb;23(2):137–148. doi: 10.1016/0166-0934(89)90127-4. [DOI] [PubMed] [Google Scholar]
  128. Jackson M. A., Burry V. F., Olson L. C. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J. 1992 Jun;11(6):441–445. doi: 10.1097/00006454-199206000-00004. [DOI] [PubMed] [Google Scholar]
  129. Jacobson M. A., Berger T. G., Fikrig S., Becherer P., Moohr J. W., Stanat S. C., Biron K. K. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1990 Feb 1;112(3):187–191. doi: 10.7326/0003-4819-112-3-187. [DOI] [PubMed] [Google Scholar]
  130. Jemsek J., Greenberg S. B., Taber L., Harvey D., Gershon A., Couch R. B. Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 1983 Mar;62(2):81–97. [PubMed] [Google Scholar]
  131. Johnson C. E., Shurin P. A., Fattlar D., Rome L. P., Kumar M. L. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics. 1988 Apr;81(4):512–518. [PubMed] [Google Scholar]
  132. Johnson C., Rome L. P., Stancin T., Kumar M. L. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics. 1989 Sep;84(3):418–421. [PubMed] [Google Scholar]
  133. Johnson R., Milbourn P. E. Central nervous system manifestations of chickenpox. Can Med Assoc J. 1970 Apr 25;102(8):831–834. [PMC free article] [PubMed] [Google Scholar]
  134. Jura E., Chadwick E. G., Josephs S. H., Steinberg S. P., Yogev R., Gershon A. A., Krasinski K. M., Borkowsky W. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1989 Sep;8(9):586–590. doi: 10.1097/00006454-198909000-00003. [DOI] [PubMed] [Google Scholar]
  135. KAPSENBERG J. G. POSSIBLE ANTIGENIC RELATIONSHIP BETWEEN VARICELLA ZOSTER VIRUS AND HERPES SIMPLEX VIRUS. Arch Gesamte Virusforsch. 1964 Sep 9;15:67–73. doi: 10.1007/BF01241422. [DOI] [PubMed] [Google Scholar]
  136. KRUGMAN S., GOODRICH C. H., WARD R. Primary varicella pneumonia. N Engl J Med. 1957 Oct 31;257(18):843–848. doi: 10.1056/NEJM195710312571801. [DOI] [PubMed] [Google Scholar]
  137. Kangro H. O., Ward A., Argent S., Heath R. B., Cradock-Watson J. E., Ridehalgh M. K. Detection of specific IgM in varicella and herpes zoster by antibody-capture radioimmunoassay. Epidemiol Infect. 1988 Aug;101(1):187–195. doi: 10.1017/s0950268800029344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Karbassi M., Raizman M. B., Schuman J. S. Herpes zoster ophthalmicus. Surv Ophthalmol. 1992 May-Jun;36(6):395–410. doi: 10.1016/s0039-6257(05)80021-9. [DOI] [PubMed] [Google Scholar]
  139. Kelley R., Mancao M., Lee F., Sawyer M., Nahmias A., Nesheim S. Varicella in children with perinatally acquired human immunodeficiency virus infection. J Pediatr. 1994 Feb;124(2):271–273. doi: 10.1016/s0022-3476(94)70317-5. [DOI] [PubMed] [Google Scholar]
  140. Kinchington P. R., Hougland J. K., Arvin A. M., Ruyechan W. T., Hay J. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol. 1992 Jan;66(1):359–366. doi: 10.1128/jvi.66.1.359-366.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Kinchington P. R., Ling P., Pensiero M., Moss B., Ruyechan W. T., Hay J. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol. 1990 Sep;64(9):4540–4548. doi: 10.1128/jvi.64.9.4540-4548.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Kinchington P. R., Vergnes J. P., Defechereux P., Piette J., Turse S. E. Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J Virol. 1994 Jun;68(6):3570–3581. doi: 10.1128/jvi.68.6.3570-3581.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Koropchak C. M., Graham G., Palmer J., Winsberg M., Ting S. F., Wallace M., Prober C. G., Arvin A. M. Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. J Infect Dis. 1991 May;163(5):1016–1022. doi: 10.1093/infdis/163.5.1016. [DOI] [PubMed] [Google Scholar]
  144. Koropchak C. M., Solem S. M., Diaz P. S., Arvin A. M. Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization. J Virol. 1989 May;63(5):2392–2395. doi: 10.1128/jvi.63.5.2392-2395.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Kuter B. J., Weibel R. E., Guess H. A., Matthews H., Morton D. H., Neff B. J., Provost P. J., Watson B. A., Starr S. E., Plotkin S. A. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine. 1991 Sep;9(9):643–647. doi: 10.1016/0264-410x(91)90189-d. [DOI] [PubMed] [Google Scholar]
  146. Kyong C. U., Smith C. D., Othersen H. B. Necrotizing fasciitis of the abdominal wall as a complication of chickenpox. Pediatr Infect Dis. 1985 Jul-Aug;4(4):420–421. doi: 10.1097/00006454-198507000-00025. [DOI] [PubMed] [Google Scholar]
  147. LaRussa P., Lungu O., Hardy I., Gershon A., Steinberg S. P., Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992 Feb;66(2):1016–1020. doi: 10.1128/jvi.66.2.1016-1020.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Landry M. L., Cohen S. D., Mayo D. R., Fong C. K., Andiman W. A. Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus. J Clin Microbiol. 1987 May;25(5):832–835. doi: 10.1128/jcm.25.5.832-835.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Landry M. L., Ferguson D. Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol. 1993 Nov;31(11):3031–3033. doi: 10.1128/jcm.31.11.3031-3033.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Lawrence R., Gershon A. A., Holzman R., Steinberg S. P. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med. 1988 Mar 3;318(9):543–548. doi: 10.1056/NEJM198803033180904. [DOI] [PubMed] [Google Scholar]
  151. LeBoit P. E., Límová M., Yen T. S., Palefsky J. M., White C. R., Jr, Berger T. G. Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndrome (AIDS). Histologic and molecular biologic findings. Am J Dermatopathol. 1992 Feb;14(1):1–7. doi: 10.1097/00000372-199202000-00001. [DOI] [PubMed] [Google Scholar]
  152. Leclair J. M., Zaia J. A., Levin M. J., Congdon R. G., Goldmann D. A. Airborne transmission of chickenpox in a hospital. N Engl J Med. 1980 Feb 21;302(8):450–453. doi: 10.1056/NEJM198002213020807. [DOI] [PubMed] [Google Scholar]
  153. Leibovitz E., Kaul A., Rigaud M., Bebenroth D., Krasinski K., Borkowsky W. Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature. Cutis. 1992 Jan;49(1):27–31. [PubMed] [Google Scholar]
  154. Levin M. J., Leventhal S., Masters H. A. Factors influencing quantitative isolation of varicella-zoster virus. J Clin Microbiol. 1984 Jun;19(6):880–883. doi: 10.1128/jcm.19.6.880-883.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Levin M. J., Murray M., Zerbe G. O., White C. J., Hayward A. R. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis. 1994 Sep;170(3):522–526. doi: 10.1093/infdis/170.3.522. [DOI] [PubMed] [Google Scholar]
  156. Liesegang T. J. Diagnosis and therapy of herpes zoster ophthalmicus. Ophthalmology. 1991 Aug;98(8):1216–1229. doi: 10.1016/s0161-6420(91)32163-8. [DOI] [PubMed] [Google Scholar]
  157. Lieu T. A., Cochi S. L., Black S. B., Halloran M. E., Shinefield H. R., Holmes S. J., Wharton M., Washington A. E. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994 Feb 2;271(5):375–381. [PubMed] [Google Scholar]
  158. Lieu T. A., Finkler L. J., Sorel M. E., Black S. B., Shinefield H. R. Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics. 1995 May;95(5):632–638. [PubMed] [Google Scholar]
  159. Liu G. T., Urion D. K. Pre-eruptive varicella encephalitis and cerebellar ataxia. Pediatr Neurol. 1992 Jan-Feb;8(1):69–70. doi: 10.1016/0887-8994(92)90057-6. [DOI] [PubMed] [Google Scholar]
  160. Ljungman P., Lönnqvist B., Ringdén O., Skinhöj P., Gahrton G. A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group. Bone Marrow Transplant. 1989 Nov;4(6):613–615. [PubMed] [Google Scholar]
  161. Locksley R. M., Flournoy N., Sullivan K. M., Meyers J. D. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis. 1985 Dec;152(6):1172–1181. doi: 10.1093/infdis/152.6.1172. [DOI] [PubMed] [Google Scholar]
  162. Lowe R. S., Keller P. M., Keech B. J., Davison A. J., Whang Y., Morgan A. J., Kieff E., Ellis R. W. Varicella-zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3896–3900. doi: 10.1073/pnas.84.11.3896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Lynfield R., Herrin J. T., Rubin R. H. Varicella in pediatric renal transplant recipients. Pediatrics. 1992 Aug;90(2 Pt 1):216–220. [PubMed] [Google Scholar]
  164. Lécuru F., Taurelle R., Bernard J. P., Parrat S., Lafay-pillet M. C., Rozenberg F., Lebon P., Dommergues M. Varicella zoster virus infection during pregnancy: the limits of prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol. 1994 Jul;56(1):67–68. doi: 10.1016/0028-2243(94)90156-2. [DOI] [PubMed] [Google Scholar]
  165. Machida H., Nishitani M. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir. Microbiol Immunol. 1990;34(4):407–411. doi: 10.1111/j.1348-0421.1990.tb01023.x. [DOI] [PubMed] [Google Scholar]
  166. Mahalingam R., Wellish M. C., Dueland A. N., Cohrs R. J., Gilden D. H. Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol. 1992 Apr;31(4):444–448. doi: 10.1002/ana.410310417. [DOI] [PubMed] [Google Scholar]
  167. Mahalingam R., Wellish M., Lederer D., Forghani B., Cohrs R., Gilden D. Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction. J Virol. 1993 Apr;67(4):2381–2384. doi: 10.1128/jvi.67.4.2381-2384.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. McGregor R. S., Zitelli B. J., Urbach A. H., Malatack J. J., Gartner J. C., Jr Varicella in pediatric orthotopic liver transplant recipients. Pediatrics. 1989 Feb;83(2):256–261. [PubMed] [Google Scholar]
  169. McKendrick M. W., McGill J. I., White J. E., Wood M. J. Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1529–1532. doi: 10.1136/bmj.293.6561.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Meier J. L., Holman R. P., Croen K. D., Smialek J. E., Straus S. E. Varicella-zoster virus transcription in human trigeminal ganglia. Virology. 1993 Mar;193(1):193–200. doi: 10.1006/viro.1993.1115. [DOI] [PubMed] [Google Scholar]
  171. Meier J. L., Straus S. E. Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. J Infect Dis. 1992 Aug;166 (Suppl 1):S13–S23. doi: 10.1093/infdis/166.supplement_1.s13. [DOI] [PubMed] [Google Scholar]
  172. Meyers J. D., Flournoy N., Thomas E. D. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J Infect Dis. 1980 Apr;141(4):479–487. doi: 10.1093/infdis/141.4.479. [DOI] [PubMed] [Google Scholar]
  173. Miller A. E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology. 1980 Jun;30(6):582–587. doi: 10.1212/wnl.30.6.582. [DOI] [PubMed] [Google Scholar]
  174. Miller E., Cradock-Watson J. E., Ridehalgh M. K. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet. 1989 Aug 12;2(8659):371–373. doi: 10.1016/s0140-6736(89)90547-3. [DOI] [PubMed] [Google Scholar]
  175. Moffat J. F., Stein M. D., Kaneshima H., Arvin A. M. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol. 1995 Sep;69(9):5236–5242. doi: 10.1128/jvi.69.9.5236-5242.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Moriuchi H., Moriuchi M., Smith H. A., Cohen J. I. Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol. 1994 Mar;68(3):1987–1992. doi: 10.1128/jvi.68.3.1987-1992.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Myers M. G., Stanberry L. R., Edmond B. J. Varicella-zoster virus infection of strain 2 guinea pigs. J Infect Dis. 1985 Jan;151(1):106–113. doi: 10.1093/infdis/151.1.106. [DOI] [PubMed] [Google Scholar]
  178. Myers M. G. Viremia caused by varicella-zoster virus: association with malignant progressive varicella. J Infect Dis. 1979 Aug;140(2):229–233. doi: 10.1093/infdis/140.2.229. [DOI] [PubMed] [Google Scholar]
  179. Nader S., Bergen R., Sharp M., Arvin A. M. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis. 1995 Jan;171(1):13–17. doi: 10.1093/infdis/171.1.13. [DOI] [PubMed] [Google Scholar]
  180. Nahass G. T., Mandel M. J., Cook S., Fan W., Leonardi C. L. Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction. J Am Acad Dermatol. 1995 May;32(5 Pt 1):730–733. doi: 10.1016/0190-9622(95)91450-1. [DOI] [PubMed] [Google Scholar]
  181. Ooi P. L., Goh K. T., Doraisingham S., Ling A. E. Prevalence of varicella-zoster virus infection in Singapore. Southeast Asian J Trop Med Public Health. 1992 Mar;23(1):22–25. [PubMed] [Google Scholar]
  182. Ozaki T., Ichikawa T., Matsui Y., Kondo H., Nagai T., Asano Y., Yamanishi K., Takahashi M. Lymphocyte-associated viremia in varicella. J Med Virol. 1986 Jul;19(3):249–253. doi: 10.1002/jmv.1890190307. [DOI] [PubMed] [Google Scholar]
  183. Ozaki T., Kajita Y., Asano Y., Aono T., Yamanishi K. Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol. 1994 Nov;44(3):263–265. doi: 10.1002/jmv.1890440309. [DOI] [PubMed] [Google Scholar]
  184. Ozaki T., Masuda S., Asano Y., Kondo K., Namazue J., Yamanishi K. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination. J Med Virol. 1994 Jan;42(1):47–51. doi: 10.1002/jmv.1890420110. [DOI] [PubMed] [Google Scholar]
  185. Pahwa S., Biron K., Lim W., Swenson P., Kaplan M. H., Sadick N., Pahwa R. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA. 1988 Nov 18;260(19):2879–2882. [PubMed] [Google Scholar]
  186. Paryani S. G., Arvin A. M. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 1986 Jun 12;314(24):1542–1546. doi: 10.1056/NEJM198606123142403. [DOI] [PubMed] [Google Scholar]
  187. Pastuszak A. L., Levy M., Schick B., Zuber C., Feldkamp M., Gladstone J., Bar-Levy F., Jackson E., Donnenfeld A., Meschino W. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med. 1994 Mar 31;330(13):901–905. doi: 10.1056/NEJM199403313301305. [DOI] [PubMed] [Google Scholar]
  188. Patterson L. E., Butler K. M., Edwards M. S. Clinical herpes zoster shortly following primary varicella in two HIV-infected children. Clin Pediatr (Phila) 1989 Aug;28(8):354–354. [PubMed] [Google Scholar]
  189. Peck R. W., Wootton R., Lee D. R., Jackson S. H., Posner J. The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent. Br J Clin Pharmacol. 1995 Feb;39(2):143–149. doi: 10.1111/j.1365-2125.1995.tb04421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Perera L. P., Kaushal S., Kinchington P. R., Mosca J. D., Hayward G. S., Straus S. E. Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27. J Virol. 1994 Apr;68(4):2468–2477. doi: 10.1128/jvi.68.4.2468-2477.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Perera L. P., Mosca J. D., Ruyechan W. T., Hay J. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol. 1992 Sep;66(9):5298–5304. doi: 10.1128/jvi.66.9.5298-5304.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Perren T. J., Powles R. L., Easton D., Stolle K., Selby P. J. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. Am J Med. 1988 Aug 29;85(2A):99–101. [PubMed] [Google Scholar]
  193. Peters A. C., Versteeg J., Lindeman J., Bots G. T. Varicella and acute cerebellar ataxia. Arch Neurol. 1978 Nov;35(11):769–771. doi: 10.1001/archneur.1978.00500350073016. [DOI] [PubMed] [Google Scholar]
  194. Plotkin S. A., Starr S. E., Connor K., Morton D. Zoster in normal children after varicella vaccine. J Infect Dis. 1989 May;159(5):1000–1001. doi: 10.1093/infdis/159.5.1000. [DOI] [PubMed] [Google Scholar]
  195. Portenoy R. K., Duma C., Foley K. M. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol. 1986 Dec;20(6):651–664. doi: 10.1002/ana.410200602. [DOI] [PubMed] [Google Scholar]
  196. Poscher M. E. Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review. AIDS. 1994 Aug;8(8):1115–1117. [PubMed] [Google Scholar]
  197. Preblud S. R. Age-specific risks of varicella complications. Pediatrics. 1981 Jul;68(1):14–17. [PubMed] [Google Scholar]
  198. Preblud S. R., Bregman D. J., Vernon L. L. Deaths from varicella in infants. Pediatr Infect Dis. 1985 Sep-Oct;4(5):503–507. doi: 10.1097/00006454-198509000-00013. [DOI] [PubMed] [Google Scholar]
  199. Preblud S. R., Orenstein W. A., Bart K. J. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis. 1984 Nov-Dec;3(6):505–509. [PubMed] [Google Scholar]
  200. Preblud S. R. Varicella: complications and costs. Pediatrics. 1986 Oct;78(4 Pt 2):728–735. [PubMed] [Google Scholar]
  201. Prober C. G., Gershon A. A., Grose C., McCracken G. H., Jr, Nelson J. D. Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J. 1990 Dec;9(12):865–869. [PubMed] [Google Scholar]
  202. Prober C. G., Kirk L. E., Keeney R. E. Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study. J Pediatr. 1982 Oct;101(4):622–625. doi: 10.1016/s0022-3476(82)80725-7. [DOI] [PubMed] [Google Scholar]
  203. Purifoy D. J., Beauchamp L. M., de Miranda P., Ertl P., Lacey S., Roberts G., Rahim S. G., Darby G., Krenitsky T. A., Powell K. L. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus. J Med Virol. 1993;Suppl 1:139–145. doi: 10.1002/jmv.1890410527. [DOI] [PubMed] [Google Scholar]
  204. Pérez J. L., García A., Niubò J., Salvà J., Podzamczer D., Martín R. Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens. J Clin Microbiol. 1994 Jun;32(6):1610–1613. doi: 10.1128/jcm.32.6.1610-1613.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. ROSS A. H. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med. 1962 Aug 23;267:369–376. doi: 10.1056/NEJM196208232670801. [DOI] [PubMed] [Google Scholar]
  206. Ragozzino M. W., Melton L. J., 3rd, Kurland L. T., Chu C. P., Perry H. O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982 Sep;61(5):310–316. doi: 10.1097/00005792-198209000-00003. [DOI] [PubMed] [Google Scholar]
  207. Ragozzino M. W., Melton L. J., 3rd, Kurland L. T., Chu C. P., Perry H. O. Risk of cancer after herpes zoster: a population-based study. N Engl J Med. 1982 Aug 12;307(7):393–397. doi: 10.1056/NEJM198208123070701. [DOI] [PubMed] [Google Scholar]
  208. Rawlinson W. D., Dwyer D. E., Gibbons V. L., Cunningham A. L. Rapid diagnosis of varicella-zoster virus infection with a monoclonal antibody based direct immunofluorescence technique. J Virol Methods. 1989 Jan;23(1):13–18. doi: 10.1016/0166-0934(89)90084-0. [DOI] [PubMed] [Google Scholar]
  209. Sadzot-Delvaux C., Merville-Louis M. P., Delrée P., Marc P., Piette J., Moonen G., Rentier B. An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res. 1990 May;26(1):83–89. doi: 10.1002/jnr.490260110. [DOI] [PubMed] [Google Scholar]
  210. Safrin S., Berger T. G., Gilson I., Wolfe P. R., Wofsy C. B., Mills J., Biron K. K. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med. 1991 Jul 1;115(1):19–21. doi: 10.7326/0003-4819-115-1-19. [DOI] [PubMed] [Google Scholar]
  211. Saltzman R., Jurewicz R., Boon R. Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob Agents Chemother. 1994 Oct;38(10):2454–2457. doi: 10.1128/aac.38.10.2454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Sawyer M. H., Chamberlin C. J., Wu Y. N., Aintablian N., Wallace M. R. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis. 1994 Jan;169(1):91–94. doi: 10.1093/infdis/169.1.91. [DOI] [PubMed] [Google Scholar]
  213. Sawyer M. H., Wu Y. N., Chamberlin C. J., Burgos C., Brodine S. K., Bowler W. A., LaRocco A., Oldfield E. C., 3rd, Wallace M. R. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella. J Infect Dis. 1992 Oct;166(4):885–888. doi: 10.1093/infdis/166.4.885. [DOI] [PubMed] [Google Scholar]
  214. Schmader K., George L. K., Burchett B. M., Pieper C. F., Hamilton J. D. Racial differences in the occurrence of herpes zoster. J Infect Dis. 1995 Mar;171(3):701–704. doi: 10.1093/infdis/171.3.701. [DOI] [PubMed] [Google Scholar]
  215. Schmidbauer M., Budka H., Pilz P., Kurata T., Hondo R. Presence, distribution and spread of productive varicella zoster virus infection in nervous tissues. Brain. 1992 Apr;115(Pt 2):383–398. doi: 10.1093/brain/115.2.383. [DOI] [PubMed] [Google Scholar]
  216. Schmidt N. J., Gallo D., Devlin V., Woodie J. D., Emmons R. W. Direct immunofluorescence staining for detection of herpes simplex and varicella-zoster virus antigens in vesicular lesions and certain tissue specimens. J Clin Microbiol. 1980 Nov;12(5):651–655. doi: 10.1128/jcm.12.5.651-655.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Schuchter L. M., Wingard J. R., Piantadosi S., Burns W. H., Santos G. W., Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood. 1989 Sep;74(4):1424–1427. [PubMed] [Google Scholar]
  218. Sharp M., Terada K., Wilson A., Nader S., Kinchington P. E., Ruyechan W. T., Hay J., Arvin A. M. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis. 1992 May;165(5):852–858. doi: 10.1093/infdis/165.5.852. [DOI] [PubMed] [Google Scholar]
  219. Shiraki K., Ochiai H., Matsui S., Aiba N., Yoshida Y., Okuno T., Yamanishi K., Takahashi M. Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus. J Gen Virol. 1992 Jun;73(Pt 6):1401–1407. doi: 10.1099/0022-1317-73-6-1401. [DOI] [PubMed] [Google Scholar]
  220. Siegel M., Fuerst H. T., Peress N. S. Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med. 1966 Apr 7;274(14):768–771. doi: 10.1056/NEJM196604072741404. [DOI] [PubMed] [Google Scholar]
  221. Spector T., Harrington J. A., Morrison R. W., Jr, Lambe C. U., Nelson D. J., Averett D. R., Biron K., Furman P. A. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. Proc Natl Acad Sci U S A. 1989 Feb;86(3):1051–1055. doi: 10.1073/pnas.86.3.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Srugo I., Israele V., Wittek A. E., Courville T., Vimal V. M., Brunell P. A. Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children. Am J Dis Child. 1993 Jul;147(7):742–745. doi: 10.1001/archpedi.1993.02160310044016. [DOI] [PubMed] [Google Scholar]
  223. Starr S. E. Varicella in children receiving steroids for asthma: risks and management. Pediatr Infect Dis J. 1992 May;11(5):419–420. [PubMed] [Google Scholar]
  224. Steinberg S. P., Gershon A. A. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J Clin Microbiol. 1991 Jul;29(7):1527–1529. doi: 10.1128/jcm.29.7.1527-1529.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Stevens D. A., Merigan T. C. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trial. Arch Intern Med. 1980 Jan;140(1):52–54. [PubMed] [Google Scholar]
  226. Straus S. E. Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections. JAMA. 1989 Dec 22;262(24):3455–3458. [PubMed] [Google Scholar]
  227. Straus S. E., Reinhold W., Smith H. A., Ruyechan W. T., Henderson D. K., Blaese R. M., Hay J. Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med. 1984 Nov 22;311(21):1362–1364. doi: 10.1056/NEJM198411223112107. [DOI] [PubMed] [Google Scholar]
  228. Takahashi M. Current status and prospects of live varicella vaccine. Vaccine. 1992;10(14):1007–1014. doi: 10.1016/0264-410x(92)90109-w. [DOI] [PubMed] [Google Scholar]
  229. Tsolia M., Gershon A. A., Steinberg S. P., Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr. 1990 Feb;116(2):184–189. doi: 10.1016/s0022-3476(05)82872-0. [DOI] [PubMed] [Google Scholar]
  230. Vafai A., Wellish M., Gilden D. H. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2767–2770. doi: 10.1073/pnas.85.8.2767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Vere Hodge R. A., Sutton D., Boyd M. R., Harnden M. R., Jarvest R. L. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]. Antimicrob Agents Chemother. 1989 Oct;33(10):1765–1773. doi: 10.1128/aac.33.10.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Wallace M. R., Bowler W. A., Murray N. B., Brodine S. K., Oldfield E. C., 3rd Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial. Ann Intern Med. 1992 Sep 1;117(5):358–363. doi: 10.7326/0003-4819-117-5-358. [DOI] [PubMed] [Google Scholar]
  233. Watson B. M., Piercy S. A., Plotkin S. A., Starr S. E. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics. 1993 Jan;91(1):17–22. [PubMed] [Google Scholar]
  234. Watson B., Boardman C., Laufer D., Piercy S., Tustin N., Olaleye D., Cnaan A., Starr S. E. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis. 1995 Feb;20(2):316–319. doi: 10.1093/clinids/20.2.316. [DOI] [PubMed] [Google Scholar]
  235. Watson B., Gupta R., Randall T., Starr S. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. J Infect Dis. 1994 Jan;169(1):197–199. doi: 10.1093/infdis/169.1.197. [DOI] [PubMed] [Google Scholar]
  236. Webster C. B., Chen D., Horgan M., Olivo P. D. The varicella-zoster virus origin-binding protein can substitute for the herpes simplex virus origin-binding protein in a transient origin-dependent DNA replication assay in insect cells. Virology. 1995 Jan 10;206(1):655–660. doi: 10.1016/s0042-6822(95)80084-0. [DOI] [PubMed] [Google Scholar]
  237. Weibel R. E., Neff B. J., Kuter B. J., Guess H. A., Rothenberger C. A., Fitzgerald A. J., Connor K. A., McLean A. A., Hilleman M. R., Buynak E. B. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med. 1984 May 31;310(22):1409–1415. doi: 10.1056/NEJM198405313102201. [DOI] [PubMed] [Google Scholar]
  238. Weller T. H. Varicella and herpes zoster: a perspective and overview. J Infect Dis. 1992 Aug;166 (Suppl 1):S1–S6. [PubMed] [Google Scholar]
  239. White C. J., Kuter B. J., Hildebrand C. S., Isganitis K. L., Matthews H., Miller W. J., Provost P. J., Ellis R. W., Gerety R. J., Calandra G. B. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics. 1991 May;87(5):604–610. [PubMed] [Google Scholar]
  240. Whitley R. J. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug;166 (Suppl 1):S51–S57. doi: 10.1093/infdis/166.supplement_1.s51. [DOI] [PubMed] [Google Scholar]
  241. Wilson A., Sharp M., Koropchak C. M., Ting S. F., Arvin A. M. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis. 1992 Jan;165(1):119–126. doi: 10.1093/infdis/165.1.119. [DOI] [PubMed] [Google Scholar]
  242. Wood M. J., Johnson R. W., McKendrick M. W., Taylor J., Mandal B. K., Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994 Mar 31;330(13):896–900. doi: 10.1056/NEJM199403313301304. [DOI] [PubMed] [Google Scholar]
  243. Wood M. J., McKendrick M. W., McGill J. I. Oral acyclovir for acute herpes zoster infections in immune-competent adults. Infection. 1987;15 (Suppl 1):S9–13. doi: 10.1007/BF01650105. [DOI] [PubMed] [Google Scholar]
  244. Wood M. J., Ogan P. H., McKendrick M. W., Care C. D., McGill J. I., Webb E. M. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med. 1988 Aug 29;85(2A):79–83. [PubMed] [Google Scholar]
  245. Zaia J. A., Levin M. J., Preblud S. R., Leszczynski J., Wright G. G., Ellis R. J., Curtis A. C., Valerio M. A., LeGore J. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis. 1983 Apr;147(4):737–743. doi: 10.1093/infdis/147.4.737. [DOI] [PubMed] [Google Scholar]
  246. Zhang Y., Cosyns M., Levin M. J., Hayward A. R. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol. 1994 Oct;98(1):128–133. doi: 10.1111/j.1365-2249.1994.tb06618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Zhu Z., Gershon M. D., Ambron R., Gabel C., Gershon A. A. Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3546–3550. doi: 10.1073/pnas.92.8.3546. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES